Lv11
34 积分 2024-06-17 加入
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
8小时前
已完结
Mechanisms of diabetic kidney disease and established and emerging treatments
8小时前
已完结
The Epidemiology of Obesity
2个月前
已完结
Wilson Confidence Intervals for Binomial Proportions With Multiple Imputation for Missing Data
2个月前
已完结
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
3个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP‐1/GIP receptor agonist (BGM0504) in healthy volunteers: A dose‐escalation Phase I study
4个月前
已完结
Sarcopenic obesity in older adults: a clinical overview
6个月前
已完结
Hypothalamic obesity: from basic mechanisms to clinical perspectives
6个月前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
6个月前
已完结
皖公网安备34019202002308
